Dr. Gaston did his Pediatric training at the National Naval Medical Center in Bethesda, MD. He served in the Navy aboard the USS Iwo Jima and at the Marine Corps base, Camp Lejeune, NC. He did his fellowship training in Pediatric Pulmonology at Boston Children’s Hospital. He is an active investigator. He has discovered 1) a new bronchodilator normally made in the lung that is broken down too rapidly in asthma; 2) abnormal airway nitrogen oxide chemistry in asthma, cystic fibrosis (CF) and primary ciliary dyskinesia; 3) abnormal airway pH regulation in lung disease; 4) a new signaling mechanism that regulates the respiratory response to red blood cell hemoglobin desaturation; 5) a new receptor-ligand system relevant to treatment of CF, asthma and other childhood lung diseases; 6) a novel respiratory stimulant; and 7) a novel mechanism whereby exercise and airway clearance benefit the airways. As a result of these discoveries, he has several grants and has helped to start several companies. These companies are translating new diagnostic ideas and therapies into clinical practice for children with respiratory disease. His goal is to provide new, personalized treatments where current treatments are ineffective. In his current role as Vice Chair for Translational Research, he has broadened the scope of this work to include a range of pediatric translational opportunities in Indiana.